Detalhe da pesquisa
1.
Comparative Analyses of Targeted Myeloid Cancer Next-Generation Sequencing Panel in Fresh Blood, Bone Marrow and FFPE Material.
Int J Mol Sci
; 25(6)2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542506
2.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695874
3.
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
Acta Haematol
; : 1-8, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848002
4.
Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice.
Hepatobiliary Pancreat Dis Int
; 22(2): 190-199, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549966
5.
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674872
6.
Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.
Molecules
; 28(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38138609
7.
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology?
Cancer Metastasis Rev
; 40(1): 153-171, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161487
8.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617104
9.
COVID-19: Challenges and solutions for the provision of care to seriously ill and dying people and their relatives during SARS-CoV-2 pandemic - perspectives of pandemic response team members: A qualitative study on the basis of expert interviews (part of PallPan).
Palliat Med
; 36(7): 1092-1103, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637612
10.
[DNVF Memorandum: Health Services Research in the Last Year of Life]. / DNVF-Memorandum Versorgungsforschung im letzten Lebensjahr.
Gesundheitswesen
; 2022 Oct 11.
Artigo
em Alemão
| MEDLINE | ID: mdl-36220106
11.
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Int J Mol Sci
; 23(8)2022 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457111
12.
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Int J Mol Sci
; 23(8)2022 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457227
13.
Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma.
Molecules
; 27(8)2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35458589
14.
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma.
Molecules
; 27(3)2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35164239
15.
[COVID-19 pandemic response teams: organization, competencies, and challenges-understanding and using structural realities]. / COVID-19-Pandemiekrisenstäbe: Organisation, Befugnisse und Herausforderungen Strukturelle Gegebenheiten verstehen und nutzen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(6): 650-657, 2022 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-35503572
16.
Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.
Cancer Immunol Immunother
; 70(12): 3405-3419, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870463
17.
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Ann Hematol
; 100(9): 2387-2398, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232360
18.
Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors.
Int J Mol Sci
; 22(11)2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34206051
19.
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.
Int J Mol Sci
; 22(2)2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435587
20.
Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 22(5)2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803402